Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dosing considerations in the pediatric patient.

T L Skaer1

  • 1College of Pharmacy, Washington State University, Pullman.

Clinical Therapeutics
|September 1, 1991
PubMed
Summary

Pediatric dosing requires individualized pharmacokinetic evaluation, not just reduced adult doses. Developing specific pediatric guidelines and dosage forms is crucial for safe and effective medication use in children.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antidepressant prescribing patterns: a comparison of blacks and whites in a medicaid population.

Clinical drug investigation·2008
Same author

The effects of soy milk and isoflavone supplements on cognitive performance in healthy, postmenopausal women.

The journal of nutrition, health & aging·2007
Same author

Trends in the rate of depressive illness and use of antidepressant pharmacotherapy by ethnicity/race: an assessment of office-based visits in the United States, 1992-1997.

Clinical therapeutics·2001
Same author

The need for an iterative process for assessing economic outcomes associated with SSRIs.

PharmacoEconomics·2001
Same author

Use of lamotrigine in a patient with bipolar disorder and psychiatric comorbidity.

Clinical therapeutics·2000
Same author

Sulfonylurea pharmacotherapy regimen adherence in a Medicaid population: influence of age, gender, and race.

The Diabetes educator·1999

Area of Science:

  • Pharmacology
  • Pediatric Medicine
  • Drug Development

Background:

  • Pediatric patients exhibit distinct pharmacokinetic profiles compared to adults, necessitating tailored medication regimens.
  • Many essential medications lack approved pediatric indications and dosing guidelines.
  • The absence of appropriate pediatric dosage forms heightens the risk of medication errors in children.

Purpose of the Study:

  • To highlight the critical need for individualized dosing in pediatric patients.
  • To emphasize the importance of developing specific pediatric dosage forms and guidelines.
  • To underscore the risks associated with using adult-dose approximations in children.

Main Methods:

  • Review of pharmacokinetic differences between pediatric and adult populations.
  • Analysis of current challenges in pediatric medication management.
  • Identification of factors influencing pediatric drug efficacy and safety.

Main Results:

  • Pediatric pharmacokinetics significantly differ, impacting drug absorption, distribution, metabolism, and excretion.
  • Lack of pediatric-specific data and formulations leads to suboptimal treatment and potential harm.
  • Age, size, and organ maturity are key determinants for safe and effective pediatric dosing.

Conclusions:

  • Individualized pharmacokinetic assessment is essential for pediatric medication management.
  • Development of specific pediatric dosing guidelines and dosage forms is imperative.
  • Adopting a "small adult" dosing approach can lead to serious adverse events in children.

Related Experiment Videos